Ignite Creation Date:
2025-12-24 @ 6:52 PM
Ignite Modification Date:
2026-01-27 @ 11:56 AM
Study NCT ID:
NCT00886457
Status:
TERMINATED
Last Update Posted:
2011-07-20
First Post:
2009-04-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
5-aza-2-deoxycytidine With Pegylated Interferon-alfa 2B: A Phase I Study With Molecular Correlates
Sponsor:
Nevada Cancer Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NVCI-0725
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Wolfram Samlowski, MD
Old Organization:
Nevada Cancer Institute